Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
Christina Ornauer, Vice President, Head of Medical Affairs of Hematology Europe at Avanzanite Bioscience, shared a post on LinkedIn:
“Attending EHA 2026 was truly inspiring, as I connected with dedicated colleagues, researchers, and healthcare professionals focused on advancing patient care.
The congress showcased the remarkable pace of innovation in hematology and emphasized the importance of collaboration within the healthcare community.
I am grateful for the opportunity to learn, exchange perspectives, and bring new insights back to my work.
Thank you to everyone who shared their expertise and passion throughout the meeting.
I look forward to seeing how these advances continue to shape the future for patients.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 13:05Angelo Zanniti: Back from EHA 2026 Congress
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
-
Jun 15, 2026, 12:46Moonmoon Kazi: Climb Bio Presents Phase 1b ITP Trial Data at EHA 2026
-
Jun 15, 2026, 12:44Wolfgang Miesbach: Base Editing and the Future of Sickle Cell Disease Therapy
-
Jun 15, 2026, 12:31Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress